In line with the observed suppressing effect of BRAT1 on its expression, Cav-1 has been described to function as a putative tumor suppressor in GBM, further highlighting the notion of targeting BRAT1 to inhibit the migrative and invasive capacity of this tumor [75]. This evidence concerns the gene CAV1 and glioblastoma.